Company
Now Is The Time To Build A Position In Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN)
Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN)’s traded shares stood at 70350.0 during the last session, with the company’s beta value hitting 0.65. At the close of
